Zhou et al. (2018) revealed a relationship between TOP2A up-regulation and poor prognosis in gliomas, and also suggested that MKI67, another hub gene found to be up-regulated in our study, is correlated with TOP2A overexpression. This evidence concerns the gene TOP2A and central nervous system cancer.